CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 337,248 shares at an average $20.21 ($6,815,190)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 99,613 shares at an average $20.35 ($2,027,158)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Planned sale Chief Financial Officer sold 5,727 shares at $18.64 ($106,751)
- 4 Open-market buy Director bought 2,000 shares at $17.08 ($34,160)
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy Director bought 2,000 shares at $19.35 ($38,700)
- 4 Planned sale Director sold 129,672 shares at $19.52 ($2,530,562)
- 4 Planned sale Director sold 688,788 shares at an average $19.09 ($13,149,314)
- 144 Insider Sale of Securities
- 4 Open-market buy Director bought 3,000 shares at $15.06 ($45,180)
Page 8 of 40 · 796 filings